JLE

Epileptic Disorders

MENU

Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study Volume 3, numéro 2, June 2001

Auteurs
Sanofi-Synthelabo, 1, avenue Pierre-Brossolette, 91385 Chilly-Mazarin Cedex, France.
  • Page(s) : 91-100
  • Année de parution : 2001

Epilepsy is the most common serious neurological condition of adults and children, occurring in approximately 50 million people worldwide [1]. Amongst the variety of different seizure types that are encountered, partial seizure is the most common [2]. Therapy for epilepsy has been available for many years but in about 30% of patients, drug treatment, often with multiple medications, fails to prevent seizures. There is therefore a continuing [...]